Cancer outcomes are shaped not just by malignant cells, but by the spatial ecosystem around them—immune neighborhoods, vasculature, and stromal...

A new early-stage clinical study reports that targeting tumor metabolism and immune recognition may offer a workable strategy for patients...

A new AI system from La Trobe University could help clinicians forecast relapse risk in patients with stage-two bowel cancer—potentially...

A new study is turning the microscopic “how it grows” question in colorectal cancer liver metastases into a measurable molecular...

The DNA damage response (DDR) and the immune system may look like separate defense networks, but new research underscores how...

Circular RNAs (circRNAs) are gaining momentum as viral-worthy candidates in the liquid biopsy revolution. Unlike linear RNAs, circRNAs form covalently...

A Mayo Clinic–led international phase 3 trial reports that a new intravesical oncolytic immunotherapy, cretostimogene grenadenorepvec, may help many people...

A new preclinical study reports that a previously underexplored biguanide-based compound, 4C, can dramatically enhance the anticancer effects of talazoparib...

The Chinese Society of Clinical Oncology (CSCO) has issued an expert consensus that aims to standardize molecular testing in pancreatic...

A new study highlights how race and ethnicity can shape not just cancer risk, but the specific medical reasons behind...